Title: cysview (hexaminolevulinate hydrocholride) for intravesical solution description: to provide the optical imaging agent, cysview (hexaminolevulinate HCL), which is the only FDA approved…
Ended Awarded
- Contract number
- HHSN261201400169U
- Awardee
-
Photocure, Inc. UEI HEK3DJVGPGX6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $54,684
Award facts
- Contract value 100% obligated
- $54,684.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Princeton, NJ 08540, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
Description
Title: cysview (hexaminolevulinate hydrocholride) for intravesical solution description: to provide the optical imaging agent, cysview (hexaminolevulinate HCL), which is the only FDA approved product for use with blue light cystoscopy
Quick answers
Who was awarded contract HHSN261201400169U?
HHSN261201400169U was awarded to Photocure, Inc. by National Cancer Institute (National Institutes of Health) on September 23, 2014.
How much is contract HHSN261201400169U worth?
The government has obligated $54,684 on HHSN261201400169U.
Is contract HHSN261201400169U an order under another contract?
Yes. HHSN261201400169U is a delivery order under V797D3030E, a federal supply schedule.
Was contract HHSN261201400169U competed?
The extent of competition for HHSN261201400169U was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award